SI-BONE, Inc. (NASDAQ:SIBN) Shares Bought by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. boosted its holdings in SI-BONE, Inc. (NASDAQ:SIBN - Free Report) by 35.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 841,045 shares of the company's stock after purchasing an additional 220,555 shares during the quarter. Harbor Capital Advisors Inc. owned about 2.01% of SI-BONE worth $11,791,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. American Century Companies Inc. boosted its holdings in SI-BONE by 22.8% in the second quarter. American Century Companies Inc. now owns 1,986,476 shares of the company's stock worth $25,685,000 after purchasing an additional 368,637 shares during the last quarter. Champlain Investment Partners LLC raised its stake in SI-BONE by 14.7% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,800,073 shares of the company's stock worth $39,145,000 after acquiring an additional 358,821 shares during the period. Paradigm Capital Management Inc. NY lifted its stake in shares of SI-BONE by 24.7% during the 2nd quarter. Paradigm Capital Management Inc. NY now owns 1,349,400 shares of the company's stock valued at $17,448,000 after buying an additional 267,100 shares in the last quarter. Impax Asset Management Group plc grew its position in shares of SI-BONE by 41.3% during the third quarter. Impax Asset Management Group plc now owns 758,521 shares of the company's stock worth $10,604,000 after purchasing an additional 221,604 shares in the last quarter. Finally, Essex Investment Management Co. LLC purchased a new position in shares of SI-BONE in the third quarter worth $2,342,000. Institutional investors own 98.11% of the company's stock.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Truist Financial lifted their price objective on SI-BONE from $16.00 to $18.00 and gave the stock a "buy" rating in a research note on Wednesday, November 13th. Needham & Company LLC restated a "buy" rating and set a $19.00 price target on shares of SI-BONE in a report on Wednesday, November 20th. Six analysts have rated the stock with a buy rating, According to data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of $23.00.

SI-BONE Trading Down 4.7 %

SIBN traded down $0.68 during trading hours on Friday, reaching $13.72. 412,087 shares of the company's stock traded hands, compared to its average volume of 281,598. The firm has a 50-day moving average price of $13.67 and a 200 day moving average price of $14.17. The firm has a market capitalization of $575.39 million, a PE ratio of -14.91 and a beta of 1.16. The company has a quick ratio of 7.22, a current ratio of 8.25 and a debt-to-equity ratio of 0.22. SI-BONE, Inc. has a 52-week low of $11.70 and a 52-week high of $21.64.

Insider Transactions at SI-BONE

In other news, insider Anthony J. Recupero sold 3,670 shares of the firm's stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $13.90, for a total transaction of $51,013.00. Following the transaction, the insider now owns 222,814 shares in the company, valued at approximately $3,097,114.60. This trade represents a 1.62 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Anshul Maheshwari sold 5,304 shares of the company's stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $13.91, for a total transaction of $73,778.64. Following the completion of the sale, the chief financial officer now directly owns 189,319 shares of the company's stock, valued at approximately $2,633,427.29. This trade represents a 2.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 27,348 shares of company stock worth $356,349. Insiders own 3.90% of the company's stock.

SI-BONE Company Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.